SCM
RPTX

Sio Capital Management’s Repare Therapeutics RPTX Stock Holding History

Sio Capital Management’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-76,049
Closed -$919K – 54
2023
Q3 		$919K Hold
76,049
– – 0.28% 38
2023
Q2 		$805K Sell
76,049
-152,489
-67% -$1.57M 0.2% 36
2023
Q1 		$2.25M Buy
+228,538
New +$2.62M 1.11% 18

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Sio Capital Management's RPTX Position: Q4 2023 in Review

Sio Capital Management sold out of Repare Therapeutics (RPTX) in Q4 2023, closing a stake of 76,049 shares — an estimated $919K sold.

Sio Capital Management first reported a position in RPTX in Q1 2023 and held it in 3 quarters. The position peaked at $2.25M in Q1 2023. 69 funds tracked by Wall St. Rank hold RPTX as of Q4 2023.

  • Sio Capital Management reported no remaining Repare Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Sio Capital Management sold 76,049 Repare Therapeutics shares in Q4 2023, an estimated $919K.
  • Sio Capital Management first reported a position in Repare Therapeutics in Q1 2023 and held it in 3 quarters.
  • Sio Capital Management's Repare Therapeutics position peaked at $2.25M in Q1 2023.
  • 69 funds tracked by Wall St. Rank held Repare Therapeutics as of Q4 2023.

Based on Sio Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.